MGLL and Anxiety: Pharmacological agents, including CB1R agonists, monoacylglycerol lipase (MAGL) inhibitors (for 2-AG), and fatty acid amide hydrolase (FAAH) inhibitors (for AEA), have demonstrated efficacy in alleviating headache and anxiety-related behaviors [10–12].